Advancements and emerging trends in ophthalmic anti-VEGF therapy: a bibliometric analysis-Reference-Cited by-同舟云学术

Advancements and emerging trends in ophthalmic anti-VEGF therapy: a bibliometric analysis

Published:2024-09-05 Issue:1 Volume:44 Page:
ISSN:1573-2630
Container-title:International Ophthalmology
language:en
Short-container-title:Int Ophthalmol

Author:

Deng Jie,Qin YuHui

Funder

The Open Fund Project of First-Class Disciplines of Hunan University of Chinese Medicine

The Key Discipline Construction Project of Ophthalmology of Traditional Chinese Medicine of the National Administration of Traditional Chinese Medicine

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s10792-024-03299-z.pdf

Reference58 articles.

1. Ghalehbandi S, Yuzugulen J, Pranjol MZI, Pourgholami MH (2023) The role of VEGF in cancer-induced angiogenesis and research progress of drugs targeting VEGF. Eur J Pharmacol 949:175586. https://doi.org/10.1016/j.ejphar.2023.175586

2. Goswami AG, Basu S, Huda F et al (2022) An appraisal of vascular endothelial growth factor (VEGF): The dynamic molecule of wound healing and its current clinical applications. Growth Fact 40(3–4):73–88. https://doi.org/10.1080/08977194.2022.2074843

3. Zhang B, Wang D, Ji TF, Shi L, Yu JL (2017) Overexpression of lncRNA ANRIL up-regulates VEGF expression and promotes angiogenesis of diabetes mellitus combined with cerebral infarction by activating NF-κB signaling pathway in a rat model. Oncotarget 8(10):17347

4. Dabravolski SA, Khotina VA, Omelchenko AV, Kalmykov VA, Orekhov AN (2022) The role of the VEGF family in atherosclerosis development and its potential as treatment targets. Int J Mol Sci 23(2):931. https://doi.org/10.3390/ijms23020931

5. Liu Y, Li Y, Wang Y et al (2022) Recent progress on vascular endothelial growth factor receptor inhibitors with dual targeting capabilities for tumor therapy. J Hematol Oncol 15(1):1–28. https://doi.org/10.1186/s13045-022-01310-7